The actions of the prostaglandins (PGs) have been suggested to play a significant role in stroke and neurodegenerative disorders. Cyclooxygenase 2 (COX-2) and PG levels increases markedly in neurons following cerebral ischemia. Previous studies in rodent stroke models have shown that COX-2 enzymatic activity promotes neuronal injury and the administration of COX-2 inhibitors reduces infarct volume. We have used transgenic mice overexpressing hCOX-2 selectively in neurons and observed an increased infarct size in the transgenic animals. Mechanisms by which PGs promote neuronal injury in stroke have not been defined. Some PGs have been reported to be toxic while others may be cytoprotective. PGs are likely to act through activation of specific PG receptors. PGs are diffusible signaling lipids whose effects are mediated through a diverse class of G-protein coupled receptors that can have opposing effects on cAMP (such as EP2, EP4, DP1) may promote neuroprotection; whereas, receptor subtypes that either decrease cAMP and signal through phosphoinositude turnover and intracellular calcium increases (such as FP, EP1, EP3 and DP2) will promote injury. Since these receptors have been cloned relatively recently, the development and availability of highly specific agonists/antagonists for in vivo use is still lacking. We will take advantage of newly available, different prostaglandin receptor knockout strain of mice to determine the effect of specific PG receptor gene deletion on neuronal injury from focal cerebral ischemia and delayed selective neuronal injury arising from cardiac arrest. The time course and localization of distinct PGs and PG receptors will be determined. Complementary experiments of oxygen/glucose deprivation and glutamate excitotoxicity will be performed on neuronal and mixed cultures from witdtype and knockouts to better define cellular mechanisms of the specific PG receptors/metabolites in regulating the outcome of ischemic damage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS046400-04
Application #
7087006
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Jacobs, Tom P
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2008-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$379,188
Indirect Cost
Name
Johns Hopkins University
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Mohan, Shekher; Koller, Emily J; Fazal, Jawad A et al. (2018) Genetic Deletion of PGF2?-FP Receptor Exacerbates Brain Injury Following Experimental Intracerebral Hemorrhage. Front Neurosci 12:556
Leclerc, Jenna L; Garcia, Joshua M; Diller, Matthew A et al. (2018) A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage. Front Mol Neurosci 11:71
Liu, Lei; Vollmer, Mary K; Fernandez, Victoria M et al. (2018) Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2. Front Cell Neurosci 12:74
Leclerc, Jenna L; Santiago-Moreno, Juan; Dang, Alex et al. (2018) Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage. J Cereb Blood Flow Metab 38:1032-1046
Leclerc, Jenna L; Lampert, Andrew S; Diller, Matthew A et al. (2016) PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice. Am J Physiol Heart Circ Physiol 310:H1725-34
Glushakov, Alexander V; Glushakova, Olena Y; Doré, Sylvain et al. (2016) Animal Models of Posttraumatic Seizures and Epilepsy. Methods Mol Biol 1462:481-519
Ma, Bo; Day, Jason Patrick; Phillips, Harrison et al. (2016) Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage. J Neuroinflammation 13:26
Glushakov, Alexander V; Arias, Rodrigo A; Tolosano, Emanuela et al. (2016) Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury. Front Mol Biosci 3:34
Ahmad, Abdullah Shafique; Shah, Zahoor Ahmad; Doré, Sylvain (2016) Protective Role of Arginase II in Cerebral Ischemia and Excitotoxicity. J Neurol Neurosci 7:
Frankowski, Jan C; DeMars, Kelly M; Ahmad, Abdullah S et al. (2015) Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Sci Rep 5:17956

Showing the most recent 10 out of 70 publications